Featured Research

from universities, journals, and other organizations

New Monitoring Technique Checks Thyroid Cancer Without Misery

Date:
December 2, 1998
Source:
Johns Hopkins Medical Institutions
Summary:
The good news about thyroid cancer is that treatment for it is relatively easy. Surgeons remove the thyroid gland and follow with a dose of radioactive iodine designed to destroy lingering cells. The bad news is that sometimes not all the cells are caught. Now a study at Johns Hopkins suggests a new way to safely and effectively detect left-over thyroid cells.

The good news about thyroid cancer is that treatment for it is relatively easy. Surgeons remove the thyroid gland and follow with a dose of radioactive iodine designed to destroy lingering cells. The bad news is that sometimes not all the cells are caught and the subsequent yearly monitoring that must follow causes patient anxiety and physical illness. Current monitoring methods also carry a slight risk of accelerating tumor growth.

Related Articles


Now a study at Johns Hopkins suggests a new way to safely and effectively detect left-over thyroid cells.

The test relies on the researchers' discovery that stray human thyroid cells can circulate in the bloodstream. It also extends the use of PCR (polymerase chain reaction) from a technique important in gene discovery and cancer diagnosis to one for patient monitoring -- a use "that will likely become standard in the near future," says endocrinologist Michael Levine, M.D., who led the research team. The study was published in this month's Journal of Clinical Endocrinology and Metabolism.

Historically, physicians look for remaining thyroid cells either by having patients take radioactive iodine, which concentrates in the thyroid gland and can be detected by scanners; or by analyzing blood for thyroglobulin, a protein made by thyroid cells. The more thyroglobulin in the bloodstream, the reasoning goes, the more thyroid cells. Physicians need both methods to pick up leftover thyroid cells that could be cancerous.

But because both tests deliver false results if patients' blood contains thyroid hormone, those under treatment and scheduled for monitoring must stop taking the thyroid hormone pills they've used daily since their thyroid gland removal. The resulting low levels of the hormone, says Levine, "quickly bring on the symptoms of hypothyroidism: People are easily tired and often depressed, their skin becomes dry, they get forgetful, their heart rate decreases, they can't tolerate cold and they become generally miserable for two to three weeks."

With the new test, patients can stay on their thyroid medicine. Based on the presence of genes for thyroglobulin, rather than on thyroglobulin itself, the test uses PCR to amplify very low level gene activity -- the sort you'd find with stray cells -- to the point where it can be detected. "The technique is extremely sensitive. It can tell, indirectly, if just one or two thyroid cells exist in a teaspoonful of blood," says Levine.

"What makes the test workable is that it needs only patients' blood. We didn't realize until now that everyone's blood contains circulating thyroid cells."

The test additionally avoids a rise in another hormone, thyroid stimulating hormone, which may encourage the growth of malignant thyroid cells. Some risk of this exists with present tests.

With an eye to widespread clinical use of the test, the research team is now clarifying whether stray cells are malignant or benign. They're also quantifying test results. "We should be able to follow levels of thyroglobulin gene activity in cancer patients -- the way you can follow HIV levels in AIDS patients -- to see how people respond to treatment. Ultimately," says Levine, "we hope assays like this will avoid the need to stop taking thyroid hormone and make monitoring faster, easier and more sensitive."

A similar assay using PCR to monitor prostate cancer treatment is being tested elsewhere.

Other researchers on the project were Matthew D. Ringel, M.D., and Paul W. Ladenson, M.D., both of Johns Hopkins. Funding for the project was from a United States Public Health Service grant and by Johns Hopkins.

Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to [email protected]

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com and ScienceDaily at http://www.sciencedaily.com.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "New Monitoring Technique Checks Thyroid Cancer Without Misery." ScienceDaily. ScienceDaily, 2 December 1998. <www.sciencedaily.com/releases/1998/12/981201105516.htm>.
Johns Hopkins Medical Institutions. (1998, December 2). New Monitoring Technique Checks Thyroid Cancer Without Misery. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/1998/12/981201105516.htm
Johns Hopkins Medical Institutions. "New Monitoring Technique Checks Thyroid Cancer Without Misery." ScienceDaily. www.sciencedaily.com/releases/1998/12/981201105516.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins